1. CME Group 2Q 2007 Earnings Conference Call July 24, 2007

2. 2 Discussion of Forward-Looking Statements Statements in this presentation that are not historical facts are forward-looking statements. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or implied in any forward-looking statements. Among the factors that might affect our performance are: our ability to successfully integrate the businesses of CME Holdings and CBOT Holdings, including the fact that such integration may be more difficult, time consuming or costly than expected; revenues following the merger may be lower than expected; increasing competition by foreign and domestic competitors, including new entrants into our markets; our ability to keep pace with rapid technological developments, including our ability to complete the development and implementation of the enhanced functionality required by our customers; our ability to continue introducing competitive new products and services on a timely, cost-effective basis, including through our electronic trading capabilities, and our ability to maintain the competitiveness of our existing products and services; our ability to adjust our fixed costs and expenses if our revenues decline; our ability to continue to realize the benefits of our transaction processing services provided to third parties; our ability to maintain existing customers and attract new ones; our ability to expand and offer our products in foreign jurisdictions; changes in domestic and foreign regulations; changes in government policy, including policies relating to common or directed clearing; the costs associated with protecting our intellectual property rights and our ability to operate our business without violating the intellectual property rights of others; our ability to generate revenue from our market data that may be reduced or eliminated by the growth of electronic trading and the redundancies in the market data offerings of Chicago Mercantile Exchange Inc. and Board of Trade of the City of Chicago, Inc.; changes in the rate per contract due to shifts in the mix of the products traded, the trading venue and the mix of customers (whether the customer receives member or non-member fees or participates in one of our various incentive programs) and the impact of tiered pricing; the ability of our financial safeguards package to adequately protect us from the credit risk of clearing firms; changes in price levels and volatility in the derivatives markets and in underlying fixed income, equity, foreign exchange and commodities markets; economic, political and market conditions; our ability to accommodate increases in trading volume without failure or degradation of performance of our systems; our ability to execute our growth strategy and maintain our growth effectively; our ability to manage the risks and control the costs associated with our acquisition, investment and alliance strategy; industry and customer consolidation; decreases in trading and clearing activity; the imposition of a transaction tax on futures and options on futures transactions; and seasonality of the derivatives business. More detailed information about factors that may affect our performance may be found in our filings with the Securities and Exchange Commission, including our most recent Quarterly Report on Form 10-Q, which is available in the Investor Relations section of the CME Group Web site. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. NOTE: Unless otherwise noted, all references to CME Group volume, open interest and rate per contract information in the text of this document exclude CME Group’s non-traditional TRAKRS SM products, for which CME Group receives significantly lower clearing fees of less than one cent per contract on average, as well as CME Group Auction Markets™ products and Swapstream ® products. Unless otherwise noted, all year, quarter and month to date volume is through 6/30/07.

3. 3 CME/CBOT Historic Merger Creates Significant Value for Shareholders and Customers Solidifies combined company’s status as the premier global exchange: Broadest product line Builds on 200+ years of innovation Provides access to CME Globex from over 80 countries Delivers operational, cost efficiencies Creates immediate scale advantages Immediately poised to capitalize on growth opportunities Deepest liquidity

4. 4 Simultaneously Completing Integration and Executing on CME Group Growth Strategy Globalizing our business Leading product and technology innovation Being a leading service provider of transaction processing services Expanding into over-the-counter/spot markets

5. 5 GAAP CME Holdings 2Q07 Financial Highlights ($s in millions, except per share) Q2 FY07 Q2 FY06 Y/Y YTD FY07 YTD FY06 Y/Y Revenues $329 $28217% $661 $53424% Expenses $137 $11519% $269 $22818% Operating Income $192 $16715% $393 $30629% Operating Margin % 58.4% 59.1% 59.4% 57.2% Net Income $126 $11015% $256 $20127% Diluted EPS $3.57 $3.1214% $7.26 $5.7327% ($s in millions, except per share) Q2 FY07 Q2 FY06 Y/Y YTD FY07 YTD FY06 Y/Y Revenues $329 $28217%$661 $53424% Expenses $130 $11512%$260 $22814% Operating Income $199 $16719%$401 $30631% Operating Margin % 60.5% 59.1% 60.7% 57.2% Net Income $130 $11019% $261 $20130% Diluted EPS $3.69 $3.1218%$7.41 $5.7329% *Non- GAAP * The non-GAAP financial measures of operating performance exclude merger-related expenses of $7.0 million for the second quarter 2007 and $8.7 million for the six months ended June 30, 2007. Non-GAAP measures do not replace and are not a substitute for GAAP financial results but are provided to improve overall understanding of current financial performance.

6. 6 CME and CBOT Average Daily Volume (ADV) 2Q 2007 CME second highest quarterly ADV CBOT highest quarterly ADV June 2007 - Records CME interest rates ADV CME equity E-mini ADV CME FX ADV CBOT interest rates ADV CBOT equity index ADV CBOT agricultural commodities ADV 6.3M 4.0M 4.3M 2.7M 668K 3.8M 184K 839K

7. 7 CME Group Electronic Options – CME Electronic E-mini Equity Options ADV Electronic Eurodollar Options ADV JUN 07 FEB 07 APR 07 JAN 07 MAR 07 MAY 07 JUN 07 FEB 07 APR 07 JAN 07 MAR 07 MAY 07 97K 146K Potential annual revenue opportunity from full migration *250M Contracts 30¢+/ contract X = $75M+ Eurodollar options example

8. 8 CME Group Electronic Options – CBOT Financial Options Traded Electronically - % Electronic %

9. 9 CME Group Transaction Processing Energy Metals Soft Commodities Transaction Processing Customer Benefits Scalable platforms Advanced functionality CME customer service standards Broad distribution/network effects Proven integration/ time-to- market advantages Increased profit potential through CME scale advantages World’s largest energy exchange $51M - 2007 Revenue [1] 10-yr exclusive agreement Note: [1] Based upon 2007 analyst consensus Future opportunities in Asia, South America and possibly Europe

10. 10 CME Group Expansion into OTC Markets Favorable Market Trends Electronic Centralized clearing Algorithmic trading Transparency/anonymity $331 $509 ADV (notional value in millions, USD) $993 Client acquisition and participation on the platform is continuing to diversify; pipeline is strong Liquidity is building; customers expressing satisfaction with bid/ask spreads and depth of book Broad geographic reach

11. 11 CME Group Expansion into OTC Markets Product benefits: No ISDA documentation required No swap confirmations No bilateral collateral Positions are automatically netted Anonymous central counterparty clearing Frees up valuable counterparty credit lines Daily mark to market minimizes financial risks Secured by CME Financial Safeguards system Streamlined processing and allocations Swaps on Swapstream First interest rate swap to offer the OTC marketplace the full benefits and financial safeguards of central counterparty clearing

12. 12 CME Group Small and Mid-Cap Equity Product Strategy S&P Small Cap Index vs. Russell 2000 Index Better performance As of June 30 th, 11.3 % return annually over 10 years vs. 9.1% More stable benchmark with lower turnover In 2006, turnover of 12.9% percent vs. 18.6% Composed of more liquid stocks and has a superior construction methodology Rolling reconstitution vs. annual reconstitution Key Strategic Advantages Established distribution Strong customer relationships Capital and cross-margining efficiencies Significant brand recognition Launching new E-mini S&P Small Cap products

13. 13 Merger Integration Milestones Finalize staffing plans (Mid-August) Providing electronic customers with dedicated testing environment (Mid-August) CME Globex cutover (January 2008) Combining trading floors (3 phases between March and May 2008)

14. 14 CME Holdings Q207 Results Versus Q206 Total revenues: +17% to $329 million Operating margin: 58% vs. 59% Net income: +15% to $126 million Diluted earnings per share (EPS): +14% to $3.57 Cash earnings: +15% to $123 million GAAPExcluding $7 million in merger-related expenses Operating margin: 61% Net income: +19% to $130 million Diluted earnings per share (EPS): +18% to $3.69

15. 15 CME Average Rate Per Contract Interest Rates Equity E-mini Equity Standard Foreign Exchange Commodities Overall RPC $0.508 0.707 1.430 1.085 0.942 $0.655 1Q074Q06 Open Outcry CME Globex Priv. Negotiated $0.512 0.660 3.713 (Excluding TRAKRS) 3Q06 $0.496 0.712 1.338 1.146 0.939 $0.641 $0.475 0.668 3.545 $0.472 0.693 1.356 1.090 1.021 $0.624 2Q07 $0.473 0.637 3.625 (excl. TRAKRS) $0.492 0.706 1.414 1.109 0.944 $0.644 $0.489 0.657 3.650 2Q06 $0.477 0.698 1.421 1.119 0.921 $0.632 $0.480 0.657 3.785

16. 16 200120022003 2004 CME Cash Earnings $88 $80 Second Quarter First Quarter Fourth Quarter ($ in millions) Third Quarter $113 $210 Note: Cash earnings = net income + depreciation + after-tax stock based compensation – capital expenditures $292 $403 2005 2006 $260 2007

17. 17 GAAP CBOT Holdings 2Q07 Financial Highlights *Non- GAAP ($s in millions, except per share) Q2 FY07 Q2 FY06 Y/Y YTD FY07 YTD FY06 Y/Y Revenues $204 $15433%$392$29433% Expenses $110 $ 8529%$208$17023% Operating Income $ 95$ 6937%$184$12448% Operating Margin % 46.3% 44.7% 47.0% 42.3% Net Income $ 58$ 4334%$114$ 7945% Diluted EPS $1.10 $0.8234% $2.15 $1.4944% ($s in millions, except per share) Q2 FY07 Q2 FY06 Y/Y YTD FY07 YTD FY06 Y/Y Revenues $204 $15433% $392 $29433% Expenses $ 90 $ 85 5% $175 $170 3% Operating Income $115 $ 6967% $217 $12475% Operating Margin % 56.1% 44.7% 55.4% 42.3% Net Income $ 72 $ 4365% $140 $ 7978% Diluted EPS $1.35 $0.8265% $2.64 $1.4977% * The non-GAAP financial measures of operating performance exclude merger-related expenses of $20.1 million for the second quarter 2007 and $33.1 million for the six months ended June 30, 2007. The CME merger-related expenses have been treated as non-deductible for tax purposes. Non-GAAP measures do not replace and are not a substitute for GAAP financial results but are provided to improve overall understanding of current financial performance.

18. 18 Fixed price tender offer commencing in the next week Providing historical pro forma volume, rate per contract, and income statement data in the next few weeks Providing ongoing guidance for CME Group at some point during Q307, likely in September CME Group – Additional Information